The Medication Level Variability Index (MLVI) as a potential predictive biomarker of graft‐versus‐host disease in pediatric hematopoietic stem cell transplant patients

2019 ◽  
Vol 23 (5) ◽  
Author(s):  
Micah A. Skeens ◽  
Mary S. Dietrich ◽  
Nancy Ryan‐Wenger ◽  
Mary Jo Gilmer ◽  
Shelagh A. Mulvaney ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document